atezolizumab
Brand: TECENTRIQ
Quick answer
atezolizumab (TECENTRIQ), is a pharmaceutical active ingredient, with approved status in the US.
Key facts
- INN
- atezolizumab
- Brand
- TECENTRIQ
- Route
- INJECTION
- Formulation
- INJECTABLE
Related news
FDA Approves Atezolizumab for ctDNA MRD-Positive MIBC
The FDA has approved Atezolizumab as an adjuvant treatment for patients with ctDNA MRD-positive muscle-invasive bladder cancer (MIBC), marking a significant advancement in oncology. This approval is expected to influence investment strategies and competitive dynamics in the pharmaceutical sector.
FDA Approves Atezolizumab for Muscle-Invasive Bladder Cancer
The FDA has approved Atezolizumab for muscle-invasive bladder cancer, marking a significant advancement in oncology treatment options. This approval has important implications for investors and pharmaceutical teams.
FDA Approves Tecentriq for Extensive-Stage Small Cell Lung Cancer
The FDA has granted approval for Tecentriq, a groundbreaking treatment for extensive-stage small cell lung cancer, enhancing options for patients in need.
Frequently asked questions
What is atezolizumab?
atezolizumab (TECENTRIQ), is a pharmaceutical active ingredient, with approved status in the US.
What is the brand name for atezolizumab?
TECENTRIQ is a marketed brand name for atezolizumab. Check FDA Drugs@FDA for the current US label holder.